Shanghai Orsin Medical Technology Co., Ltd. Şirket Profili

Ürünler

Evde > Ürünler > Vakumlu kan testi tüpü > Cell-Free DNA-Based Test Tube with High Precision & Personalization for Early Disease Detection

Cell-Free DNA-Based Test Tube with High Precision & Personalization for Early Disease Detection

Ürün Ayrıntıları

Menşe yeri: Çin

Marka adı: Orsin

Ödeme ve Nakliye Şartları

Min sipariş miktarı: 100

Fiyat: pazarlık edilebilir

Ödeme koşulları: L/C, D/A, D/P, T/T, Western Union

En İyi Fiyatı Alın

Şimdi konuşalım.

Ürün Ayrıntıları

Ürün Tanımı

Ürün Ayrıntıları

Vurgulamak: 
                                                                                                                                                                                                                                                Cell-Free DNA test tube high precision, Personalized disease detection test tube, Vacuum blood test tube early detection
                              

Malzeme:	cam ve plastik	Özellik:	Özelleştirme
Kapasite:	Özelleştirme	Ürün adı:	DHA steril ve güvenli
Klinik kullanım:	Kan bankası	karakteristik:	Sıvı biyopsi

Malzeme:	cam ve plastik
Özellik:	Özelleştirme
Kapasite:	Özelleştirme
Ürün adı:	DHA steril ve güvenli
Klinik kullanım:	Kan bankası
karakteristik:	Sıvı biyopsi

Ürün Tanımı

Product Description

This cell-free DNA test tube is a cutting-edge diagnostic tool designed for early disease detection, integrating high precision and personalized testing capabilities.
Crafted with advanced molecular technology, the test tube enables accurate capture and analysis of cell-free DNA, providing reliable data support for early disease screening.
A professional-grade testing solution, it combines user-friendly operation with superior performance to meet the needs of clinical and research scenarios.

2. Specification

Parameter	Description/Options
Tube Cap Color	Red, Lavender (Purple), Green, Gray, Blue, Yellow, Black, etc.
Additive Type	None (Clot activator), EDTA, Heparin, Sodium Citrate, Sodium Fluoride, etc.
Clinical Use	Serum separation, Hematology, Coagulation, Chemistry, Glucose, Blood Bank, etc.
Nominal Volume	2ml, 3ml, 4ml, 5ml, 6ml, 7ml, 8ml, 10ml, etc.
Draw Volume Range	±10% of nominal volume (e.g., 4.5-5.5ml for 5ml tube)
Tube Diameter	13mm, 16mm (standard adult size)
Tube Length	75mm, 100mm, etc.
Material	PET plastic, Glass
Sterilization	Gamma irradiation, EO Gas
Expiry Period	Typically 12-36 months (from date of manufacture)
Hemolysis Rate	≤0.1% (for most chemistry tubes)
Clotting Time	30 mins (for serum tubes with clot activator)
Centrifuge Speed	1300-2200g (tube material dependent)
Safety Features	Hemogard™ closure, BD-PTS, Needle protection system
Certifications	ISO 6710, CE Marked, FDA 510(k)

Common Parameters by Tube Color (Example):

Cap Color	Additive	Mixing	Inversion Count	Clinical Applications
Red	None/Clot activator	5×	5-6	Serum chemistry, Immunology
Lavender	K2/K3 EDTA	8-10×	8-10	Hematology (CBC, Blood Smear)
Green	Lithium Heparin	8-10×	8-10	Plasma chemistry, STAT tests
Gray	NaF/K Oxalate	8-10×	8-10	Glucose tolerance, Alcohol tests
Blue	Sodium Citrate	3-4×	3-4	Coagulation tests (PT, APTT)

3 .

Product Features

High Precision: Utilizes advanced detection technology to ensure high sensitivity and specificity, minimizing false positive/negative results.
Personalization: Tailors testing parameters based on individual biological characteristics for more targeted and relevant outcomes.
Early Detection Capability: Identifies trace amounts of abnormal cell-free DNA at the early stage of disease, enabling timely intervention.
Reliable Performance: Manufactured with strict quality control standards, ensuring stable and consistent results across multiple uses.
User-Friendly: Designed with a simple workflow, compatible with common laboratory equipment for easy integration.

Applications

Clinical Settings: Suitable for early screening of tumors, genetic diseases, and other chronic conditions in hospitals and clinics.
Research Institutions: Ideal for molecular biology research, disease mechanism studies, and diagnostic technology development.
Health Management: Applicable to high-risk groups for regular health monitoring and early disease prevention.
Precision Medicine: Supports personalized treatment planning by providing accurate early diagnostic data for healthcare providers.